12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several healthcare stocks experienced significant movements. Harpoon Therapeutics (HARP) saw a 110.9% increase, while Ambrx Biopharma (AMAM) rose by 101.76%. Vincerx Pharma (VINC) and Ampio Pharmaceuticals (AMPE) also gained, with increases of 52.54% and 27.52%, respectively. Cyclacel Pharmaceuticals (CYCC) and Axonics (AXNX) both saw their stocks rise by over 20%. Conversely, LumiraDx (LMDX) dropped by 32.6%, and other stocks such as Sharps Technology (STSS), Ainos (AIMD), Biofrontera (BFRI), Elevation Oncology (ELEV), and Cytokinetics (CYTK) also experienced declines.
January 08, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ambrx Biopharma's stock increased by 101.76% to $27.5, with a market cap of $1.7 billion.
The significant rise in Ambrx Biopharma's stock price indicates a bullish outlook that may continue to positively impact the stock in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Harpoon Therapeutics stock soared by 110.9% to $22.25, with a market cap of $376.7 million.
The substantial pre-market gain for Harpoon Therapeutics suggests a strong positive sentiment that could lead to further short-term price increases if the momentum continues.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
LumiraDx shares fell sharply by 32.6% to $0.02, with a market cap of $7.4 million.
The significant drop in LumiraDx's stock price could indicate negative sentiment or adverse events, likely leading to further short-term declines.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100